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Abstract
AIM: To investigate the effects of tachyplesin and n-so-
dium butyrate on proliferation and gene expression of 
human gastric adenocarcinoma cell line BGC-823.
METHODS: Effects of tachyplesin and n-sodium 
butyrate on proliferation of BGC-823 cells were deter-
mined with trypan blue dye exclusion test and HE stain-
ing. Effects of tachyplesin and n-sodium butyrate on cell 
cycle were detected by flow cytometry. Protein levels of 
c-erbB-2, c-myc, p53 and p16 were examined by immu-
nocytochemistry.
RESULTS: The inhibiting effects were similar after 2.0 
mg/L tachyplesin and 2.0 mmol/L n-sodium butyrate 
treatment, the inhibitory rate of cellular growth was 
62.66% and 60.19% respectively, and the respective 
maximum mitotic index was decreased by 49.35% and 
51.69% respectively. Tachyplesin and n-sodium butyrate 
treatment could markedly increase the proportion of cells 
at G0/G1 phase and decrease the proportion at S phase. 
The expression levels of oncogene c-erbB-2, c-myc, and 
mtp53 proteins were down-regulated while the expres-
sion level of tumor suppressor gene p16 protein was 
up-regulated after the treatment with tachyplesin or 
n-sodium butyrate. The effects of 1.0 mg/L tachyplesin 
in combination with 1.0 mmol/L n-sodium butyrate were 
obviously superior to their individual treatment in chang-
ing cell cycle distribution and expression of c-erbB-2, 
c-myc, mtp53 and p16 protein. The inhibitory rate of 
cellular growth of BGC-823 cells after combination treat-
ment was 62.29% and the maximum mitotic index was 
decreased by 51.95%.
CONCLUSION: Tachyplesin as a differentiation inducer 
of tumor cells has similar effects as n-sodium butyrate 
on proliferation of tumor cells, expression of correlative 
oncogene and tumor suppressor gene. It also has a syn-
ergistic effect on differentiation of tumor cells.
© 2006 The WJG Press. All rights reserved.
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INTRODUCTION
Tachyplesin, isolated from acid extracts of  hemocytes of  
Chinese horseshoe crab (Tachypleus tridentatus), a sort of  
marine arthropod known as “live fossil”, is a low-molec-
ular-weight polypeptide [1]. This bioactive component has 
antitumor effect and induces tumor cell differentiation [2]. 
We used the small molecule polar compound n-sodium 
butyrate[3] as a parallel control to compare the effects on 
proliferation, cell cycle and expression of  correlative onco-
gene and tumor suppressor gene of  BGC-823 cells treated 
with tachyplesin, n-sodium butyrate and their combina-
tion. This research could provide information for further 
identification of  antitumor low-molecular-weight crude 
bioactive peptides such as tachyplesin that can modulate 
the proliferation and differentiation of  tumor cells.
MATERIALS AND METHODS
Tachyplesin isolation and extraction
Tachyplesin was isolated from acid extracts of  Chinese 
horseshoe crab (Tachypleus tridentatus) hemocytes as previ-
ously described[4]. The crude extract was separated by 
SephadexG-50, CM-sepharose CL-6B column chromatog-
raphy.
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Cell culture 
BGC-823 cells were cultured in RPMI-1640 medium sup-
plemented with 20% heat-inactivated fetal calf  serum,100 
units/mL penicillin,100 mg/L streptomycin and 50 mg/L 
kanamycin at 37℃ in atmosphere containing 50 mL/L 
CO2. BGC-823 cells were treated with culture medium 
containing inducers after seeded for 24 h.
Inducing treatment
The powder of  tachyplesin obtained from separation, 
purification and lyophilization was dissolved in D-Hank’s 
solution to prepare 100 mg/L concentrated solution. The 
mother liquor was prepared for solution of  a given con-
centration with culture medium. N-sodium butyrate pur-
chased from Sigma Co., was dissolved in appropriate con-
centration of  D-Hank’s solution to prepare 200 mmol/ L 
concentrated solution. The concentrations of  the three 
treatment solutions were as follows: 2.0 mg/L tachyplesin-
treatment (Ta), 2.0 mmol/L n-sodium butyrate-treatment 
(Tb), and 1.0 mg/L tachyplesin + 1.0 mmol/L n-sodium 
butyrate for the combination treatment (Ta+Tb). The 
experimental groups were treated with the three reagents 
after medium was changed, while the control group was 
cultured continuously with fresh culture medium for future 
use.
Determination of cell growth curve
BGC-823 cells were collected in logarithmic phase, then 
suspension of  BGC-823 cells was made in 5.0×104 cells/
mL. The cells were seeded into 15 mL culture flasks with 
2 mL per flask. After seeded for 24 h, the experimental 
groups were treated with the reagents containing differ-
ent kinds of  differentiation-induced gradients while the 
control group was cultured continuously in fresh culture 
medium. During the first seven days, untreated or treated 
cells were harvested from three flasks everyday, and the 
viable cells were counted by the trypan blue dye exclusion 
test to get average value. The similar results were found in 
triplicate experiments, the growth curve was derived from 
one of  the results.
Determination of cell mitotic index
BGC-823 cells (5.0×104 mL) were seeded in to bottles 
containing little penicillin with cover slips. Treatments 
were performed after the cells were seeded for 24 h. 
During the first seven days, the cover slips were removed 
from two bottles of  the untreated or treated cells everyday, 
fixed in Bouin-Hollande fixative, and stained with Hema-
toxylin-Eosin (HE). The mitotic cells in 1000 cells on each 
cover slip were counted, and the mitotic index curve was 
drawn.
Determination of cell cycle
BGC-823 cells were collected respectively from the treated 
groups and the control group after digested and centri-
fuged at 1000 r/min for 5 min. All the cells collected were 
rinsed three times with D-Hank’s solution. The cells grown 
on cover slips were fixed in 75% pre-cooled ethanol at 4 
℃ overnight, centrifuged and resuspended in 100 mg/L 
RNase at 37℃ for 30 min. Then 50 mg/L propidium 
iodide was added into the suspended cells at 4 ℃ in dark 
for 30 min. The cell cycle was analyzed by flow cytometry 
(Bacton-Dickson Co.) and the data were analyzed by Cell 
FIT cell cycle analysis software（Version2.01.2）.
Immunohistochemical analysis
BGC-823 cells (5.0×104/mL) and cells treated with differ-
ent inducers were seeded into bottles containing little peni-
cillin with cover slips for 36 h respectively. The cells grown 
on cover slips were rinsed with D-Hank’s solution at 37℃. 
The changes in c-erbB-2, c-myc , p53 and p16 expression 
of  treated and untreated BGC-823 cells were determined 
by SABC immunohistochemical assay. The reagent kit 
(Wuhan Boster Bioengineering Corporation) was used to 
determine the expression of  these genes. PBS was used to 
take the place of  primary antibody as the negative controls 
and positive specimens were used as positive controls.
RESULTS
Effects of tachyplesin and n-sodium butyrate on prolifera-
tion of BGC-823 cells
The cell growth curve determination showed that the pro-
liferation of  untreated BGC-823 cells was very fast. The 
cell number increased to 91.29×104/mL on the seventh 
day which was 18.26 times of  that of  the original 5.0×
104/mL on the first day, with a doubling time of  45.82 
h. However, after treated with tachyplesin or n-sodium 
butyrate, the growth rate of  BGC-823 cells was inhibited. 
After treatment with 2.0 mg/L tachyplesin, the number 
of  cells was 34.09×104/mL which was 6.8 times of  that 
of  the original number on the 7th day, with the doubling 
time prolonged to 75.7 h and the growth inhibitory rate 
increased to 62.77%. After treatment with 2.0 μg/mL 
n-sodium butyrate, the number of  cells was 36.34×104/
mL which was 7.27 times of  that of  the original number 
on the 7th day, the doubling time was 67.10 h and the 
growth inhibitory rate was 60.19%. After treatment with 
1.0 mg/L tachyplesin + 1.0 mmol/L n-sodium butyrate, 
the number of  cells was 33.87×104/mL on the 7th day, the 
doubling time was 69.75 h and the growth inhibitory rate 
was 62.29% (Figure 1).
The cell mitotic index determination showed that 
BGC-823 cells had vigorous proliferation capability, which 
reached to the divided peak on the fourth day and the 
maximum mitotic index was 38.5‰. However the mitotic 
Figure 1  Cell growth inhibition in BGC-823 cells after tachyplesin, n-sodium 
butyrate and their combination treatment (×104 cells/mL).
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index of  cells treated with tachyplesin or n-sodium bu-
tyrate or their combination was only 19.5‰, 18.6‰ and 
18.5‰ respectively at the divided peak, and declined by 
49.35％, 51.69％ and 51.95% respectively. The divided 
peak occurred on the third day after inducing treatment 
(Figure 2A).
Effects of tachyplesin and n-sodium butyrate on cell cycle 
of BGC-823 cells
Cell cycle of  BGC-823 cells was analyzed by flow cytom-
etry. The results showed that the cell cycle distribution 
of  BGC-823 cells changed obviously when the cells were 
treated with tachyplesin or n-sodium butyrate. The propor-
tion of  untreated cells was 50.7% in G0/G1 phase, 39.1% in 
S phase and 10.2% in G2+M phase. However, the propor-
tion of  cells at G0/G1 phase was 59.5%, 26.3% at S phase 
and 14.2% at G2+M phase after treated with 2.0 mg/L 
tachyplesin. Similar changes occured in cells treated with 
2.0 mmol/L n-sodium butyrate r the proportion of  cells 
in G0/G1 phase was 59.2%, 25.2% in S phase and 15.6% 
in G2+M phase. Meanwhile, the proportion of  BGC-823 
cells increased from 50.7% to 64.5% in G0/G1 phase and 
decreased from 39.1% to 20.9% in S phase(Table 1). The 
proportion of  cells in G2+M phase increased from 10.2% 
to 14.6%(Figure 2B). 
Effects of tachyplesin and n-sodium butyrate on expres-
sion of oncogene and tumor suppressor gene of BGC-823 
cells
Immunocytochemistry showed that c-erbB-2 protein level 
in the control group was high. The dark brown-yellow 
granules were mainly detected in cytoplasm and membrane 
of  BGC-823 cells. But in nuclei, the protein level was low, 
while a few unevenly-distributed buff  granules could be 
detected (Figure 3A). After treated with tachyplesin, the 
positive rate of  c-erbB-2 expression in BGC-823 cells de-
creased. The brown-yellow particles were mainly detected 
in cytoplasm around nuclear membrane but a few in nuclei 
(Figure 3B). After treated with n-sodium butyrate,relatively 
bigger brown-yellow granules were mainly detected in nu-
clei and cytoplasm around the nuclei but a few around the 
cell membrane(Figure 3C). After treated with the combina-
tion of  the two inducers, the immunocytochemistry signal 
became weaker than after treated with n-sodium butyrate 
alone. The smooth and evenly-distributed brown-yellow 
granules were mainly detected in nucleoli and nuclear 
membrane of  the cells (Figure 3D).
Immunocytochemistry showed that the c-MYC pro-
tein level in the control group was high, the brown gran-
ules were mainly detected in nuclei and cytoplasm around 
the nuclei of  BGC-823 cells (Figure 3E). After treated with 
tachyplesin, the level of  c-MYC protein in BGC-823 cells 
decreased. The light brown-yellow granules were mainly 
detected in karyoplasms around the nuclear membrane, 
while in nuclei, the protein level was very low (Figure 3F). 
After treated with n-sodium butyrate, the brown particles 
were mainly detected in nucleoli and cytoplasm, while in 
nuclei of  the cells, the signal was almost negative (Figure 
3G). After treated with combination of  the two inducers, 
the signal became weaker than after treated with n-sodium 
butyrate alone. The evenly-distributed brown-yellow gran-
ules were mainly detected in nucleoli and cytoplasm while 
in nuclei of  the cells, the signal could be scarcely detected 
(Figure 3H).
Immunocytochemistry showed that mtP53 protein 
level in the control group was high. The dark brown-yellow 
granules were mainly detected in nuclei, while a few gran-
ules were detected in cytoplasm of  BGC-823 cells. Their 
distributing was irregular(Figure 3I). After treated with 
tachyplesin, the rate of  positive expression of  mtP53 in 
BGC-823 cells decreased. The light brown-yellow granules 
were mainly detected in cytoplasm, while in nuclei of  the 
cells the expression was negative (Figure 3J). After treated 
with n-sodium butyrate, the light brownish-red granules 
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Figure 2  Influence of tachyplesin, n-sodium butyrate and their combination on 
mitotic index (A) and cell cycle (B) of BGC-823 cells.
A
B
 Table 1 Influence of tachyplesin, n-sodium butyrate  and 
 their combination on cell cycle of BGC-823 cells (%)
Group G0/G1 S G2/M
BGC-823 50.7 39.1 10.2
Ta 59.5 26.3 14.2
Sb 59.2 25.2 15.6
Ta+Sb 64.5 20.9 14.6
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were mainly detected in cytoplasm, while in nuclei of  the 
cells, the mtP53 expression decreased greatly, and the sig-
nal became almost negative(Figure 3K). After treated with 
combination of  the two inducers, the immunocytochemis-
try signal as a whole became weaker than after treated with 
n-sodium butyrate alone. The light brown granules were 
mainly detected in cytoplasm and could be hardly detected 
in nuclei of  the cells (Figure 3L).
Immunocytochemistry showed that P16 protein level 
in the control group was low. The brown-yellow granules 
were detected in nucleoli and cytoplasm around the nuclear 
membrane of  BGC-823 cells. The signal in cytoplasm and 
cell membrane was very weak (Figure 3M). However, after 
treated with tachyplesin, the P16 protein level in BGC-823 
cells became very high. The evenly-distributed brown gran-
ules were detected in cytoplasm (Figure 3N). After treated 
with n-sodium butyrate, the P16 protein level became high. 
The brown granules were mainly detected in cytoplasm in 
a spare and dispersed manner. Some smaller granules were 
detected in marginal area of  cytoplasm and protuberance 
of  cells (Figure 3Q). After treated with combination of  the 
two inducers, the P16 protein level became very high. The 
evenly-distributed brown granules were mainly detected in 
nucleoli and cytoplasm. The protein level in the combina-
tion treatment group was higher than in the group treated 
with n-sodium butyrate alone and the signal in nucleoli 
Figure 3  Expression of c-erbB-2 (A-D), c-myc (E-H), p53 (I-L), and p16 (M-R) in BGC-823 cells, tachyplesin-treated cells, n-sodium butyrate-treated cells, and tachyplesin 
+ n-sodium butyrate-treated cells. ×536
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became very strong (Figure 3R).
DISCUSSION
Sine continual division and constant proliferation are im-
portant characteristics of  tumor cells, the proliferation of  
tumor cells is one of  the significant indexes in identifying 
exogenous inducers of  differentiation [5]. In our study, the 
cell growth curve, mitotic index and cell cycle indicated 
that BGC-823 cells had vigorous proliferation capabil-
ity, the doubling time was 45.82 h, the maximum mitotic 
index was 38.5%, and the proportion of  cells was 50.7% 
in G0/G1 phase and 39.1% in S phase. However the dou-
bling time of  cells treated with tachyplesin or n-sodium 
butyrate was 75.7 h and 67.1 h respectively, the rate of  cell 
growth inhibition was 62.66% and 60.19% respectively, the 
maximum mitotic index decreased to 12.6% and 10.9% 
respectively, the proportion of  cells in G0/G1 phase was 
59.5% and 59.2% respectively, while the proportion of  
BGC-823 cells in S phase decreased to 26.3% and 25.2% 
respectively. The results demonstrated that the inhibitory 
effects of  tachyplesin and n-sodium butyrate on prolifera-
tion of  BGC-823 cells were significant. n-sodium butyrate, 
a small molecule polar compound, has been widely used in 
inducing differentiation of  tumor cells [3, 6, 7]. The effects of  
n-sodium butyrate on cell growth and cell cycle are coinci-
dent with the reports about the anti-proliferative effects of  
n-sodium butyrate on the cell cycle arrest of  human gastric, 
colonic and endometrial carcinoma cell lines [6-9]. Our experi-
ment showed that the effects of  tachyplesin and n-sodium 
butyrate on cell growth and cell cycle of  BGC-823 were 
similar, indicating that tachyplesin has identical effects on 
inhibiting proliferation as chemical inducers of  cancer 
cells.
The changes in expression of  oncogenes and tumor 
suppressor genes play a role in cell carcinogenesis and re-
versal movement, amplification and inactivation of  some 
associated genes such as c-erbB-2, c-myc, p53, p16 [10-11] are 
a main index in differentiation of  human gastric carcinoma 
cells [11]. In our study, the levels of  c-erbB2, c-myc, mtp53 
proteins were high but p16 expression was low in untreat-
ed BGC-823 cells. However, after treated with tachyplesin 
or n-sodium butyrate, the level of  c-erbB-2, c-myc, mtp53 
proteins decreased and p16 protein expression increased 
significantly in BGC-823 cells, demonstrating that both 
tachyplesin and n-sodium butyrate can influence the ex-
pression of  oncogenes and tumor suppressor genes. Previ-
ous studies showed that n-sodium butyrate could down-
regulate the expression of  oncogenes (c-erbB-2, c-myc, 
p53) and up-regulate the expression of  tumor suppressor 
genes (p16) in endometrial and colonic carcinoma and 
melanoma[7,8,12,13], confirming that n-sodium butyrate has 
obvious effects on differentiation of  BGC-823 cells. Our 
results also showed that tachyplesin had the same effect on 
up-regulating the expression of  tumor suppressor genes 
and down-regulating the expression of  oncogenes as n-so-
dium butyrate in BGC-823 cells.
The combination of  different inducers may have a 
synergistic effect on differentiation and reduce toxicity and 
side effects by cutting down the dosage. It is not only an 
important subject in the field of  differentiation, but also 
has a positive impact on the clinical application of  differ-
ent therapies for cancer [14]. Our study showed that at the 
concentration of  1.0 g tachyplesin + 1.0 mmol/L n-sodium 
butyrate, the growth inhibitory rate was 62.29%, the mi-
totic index decreased to 18.5‰ at the divided peak and the 
proportion of  cells in G0/G1 phase increased to 64.5% and 
decreased to 20.9% in S phase. Immunocytochemistry also 
showed that the levels of  c-erbB-2, c-myc, p53 proteins in 
BGC-823 cells treated with the combination were lower 
and the level of  p16 protein was higher. 
In conclusion, tachyplesin has synergistic effects with 
n-sodium butyrate and can be used in treatment of  cancer. 
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